Sienabiotech enters r&d collaboration with Chemical Diversity Labs
US company Chemical Diversity Labs, a leading provider of discovery chemistry services, has entered into an innovative research collaboration with Sienabiotech, of Siena in Italy, for evaluation and screening of a focused library.
US company Chemical Diversity Labs, a leading provider of discovery chemistry services, has entered into an innovative research collaboration with Sienabiotech, of Siena in Italy, for evaluation and screening of a focused library.
Under the terms of the agreement, Sienabiotech, an integrated drug discovery company focused on CNS disorders, will use its methods and technology to screen the aspartyl protease focused library provided by CDL. To create the library, CDL applied its knowledge driven methods of focused library design, and additionally performed diversity optimisation.
'Through this collaboration we expect to enhance the efficiency of our integrated drug discovery process,' said Georg C. Terstappen, vp discovery research at Sienabiotech. 'Using Chemical Diversity Labs' compound collection and predictive technologies used to focus these libraries, we believe we can increase the chances of identifying high-quality leads.'